Andrea Giaccari, MD, PhD; Carlo B. Giorda, MD; Gabriele Riccardi, MD; Alberto De Micheli, MD; Graziella Bruno, MD; Luca Monge, MD; Simona Frontoni, MD, PhD
Potential Conflicts of Interest: None disclosed.
Giaccari A, Giorda CB, Riccardi G, De Micheli A, Bruno G, Monge L, et al. Evaluation of Guidelines on Diabetes Medication. Ann Intern Med. 2012;156:752-753. doi: 10.7326/0003-4819-156-10-201205150-00020
Download citation file:
Published: Ann Intern Med. 2012;156(10):752-753.
TO THE EDITOR:
We read Bennett and colleagues' review (1) with interest. It is unfortunate that the authors restricted their research to the U.S., U.K., and Canadian databases because they “deemed these countries' guideline developers most likely to access and use the systematic review.”
The Italian Standards for the Treatment of Diabetes Mellitus (2) represents a consensus document of the 2 Italian scientific diabetes societies (Società Italiana di Diabetologia and Associazione Medici Diabetologi) that provides specific recommendations for the diagnosis and treatment of diabetes and its complications. An original processing system was used to create these recommendations: The document prepared by the editorial team was published online for 20 days, and the suggestions and criticisms of all of the Società Italiana di Diabetologia, and Associazione Medici Diabetologi members were evaluated and integrated with those from a panel of diabetologists and members of other health care professions committed to diabetes care, as well as lay members, including patient representatives. These guidelines include recommendations on oral medications for type 2 diabetes mellitus.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only